# A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

> **NCT02215954** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 637 (actual)

## Conditions studied

- Colon Cleansing in Preparation for Colonoscopy

## Interventions

- **DRUG:** FE 999169
- **DRUG:** Niflec

## Key facts

- **NCT ID:** NCT02215954
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 637 (ACTUAL)
- **Last updated:** 2017-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215954, "A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02215954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*